08048035996
Bosutris 100mg Good Quality Tablet to UK - London | Phoenix Exim | Trusted Exporter

1. General Information

Bosutris 100 mg Tablet is an oral targeted cancer therapy containing bosutinib 100 mg. Bosutinib is a kinase inhibitor that targets abnormal signaling involved in the growth of certain leukemia cells. It is primarily used for adults with Ph+ CML, including newly diagnosed chronic-phase disease and certain patients whose previous CML treatment was ineffective or not tolerated. Current U.S. prescribing information also includes pediatric patients aged 1 year and older for certain chronic-phase Ph+ CML indications.

  • Brand: Bosutris 100 mg
  • Active ingredient: Bosutinib 100 mg
  • Dosage form: Tablet
  • Therapeutic class: Anticancer / Tyrosine kinase inhibitor
  • Route: Oral
  • Prescription medicine: Yes
  • Manufacturer/Marketer reported in India: Mylan Pharmaceuticals Pvt Ltd

2. Product Information

Bosutris 100 mg contains bosutinib, a targeted therapy used in the management of Ph+ CML. The medicine is supplied as an oral tablet and should be taken exactly according to the oncologist's prescription.

The 100 mg strength is one of the available bosutinib tablet strengths; the appropriate strength and treatment schedule depend on the patient's disease phase, treatment history, response and tolerability.

3. Uses of Bosutris 100 mg

Bosutris 100 mg is used under specialist medical supervision for Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).

Depending on the approved indication and patient circumstances, bosutinib may be used for:

  • Newly diagnosed chronic-phase Ph+ CML
  • Chronic-phase Ph+ CML where previous therapy has not worked or was not tolerated
  • Accelerated- or blast-phase Ph+ CML in adults with resistance or intolerance to previous therapy

4. Benefits of This Medicine

The main therapeutic benefit of bosutinib is its ability to inhibit abnormal kinase signaling that contributes to the uncontrolled growth of leukemia cells.

Potential treatment benefits include:

  • Helps control the growth and multiplication of CML cells.
  • Helps reduce abnormal leukemia-cell signaling.
  • Can help achieve hematologic, cytogenetic or molecular responses in appropriate patients.
  • Provides a targeted treatment option for patients with Ph+ CML.
  • May be used when previous CML treatments have failed or cannot be tolerated, depending on the approved indication.

Treatment response varies between patients and should be evaluated through regular medical examinations and laboratory testing.

5. Side Effects

Bosutinib can cause side effects, and some may require medical attention. Important adverse effects identified in prescribing information include:

  • Diarrhea
  • Abdominal pain
  • Nausea
  • Vomiting
  • Rash
  • Fatigue
  • Headache
  • Fever
  • Decreased appetite
  • Liver-function abnormalities
  • Respiratory tract infections
  • Changes in blood-cell counts
  • Fluid retention
  • Kidney-function abnormalities
  • Cardiovascular problems in some patients

Serious symptoms such as severe diarrhea or vomiting, unusual bleeding, breathing difficulty, chest pain, significant swelling, jaundice or signs of infection should be reported promptly to a healthcare professional.

6. Common Side Effects

Frequently reported adverse reactions include:

  • Diarrhea
  • Abdominal discomfort or pain
  • Nausea
  • Vomiting
  • Rash
  • Tiredness
  • Headache
  • Fever
  • Reduced appetite
  • Constipation
  • Respiratory tract infection
  • Increased liver enzymes

The prescribing physician may adjust, interrupt or discontinue treatment depending on the severity of adverse reactions.

7. How to Use Bosutris 100 mg

Bosutris should be taken only according to the oncologist's prescription.

General administration guidance:

  • Take the tablet orally as prescribed.
  • Bosutinib is generally taken with food.
  • Take it at approximately the same time each day.
  • Swallow the tablet whole.
  • Do not crush, chew or split the tablet unless specifically instructed by a healthcare professional.
  • Do not change the dose or stop treatment without consulting the prescribing physician.

The exact dose is individualized. Do not assume that one 100 mg tablet is the appropriate daily dose simply because the product strength is 100 mg.

8. How This Medicine Works

Bosutinib is a tyrosine kinase inhibitor. In Ph+ CML, abnormal BCR::ABL1 kinase signaling promotes uncontrolled growth and survival of leukemia cells.

Bosutinib inhibits this abnormal kinase signaling, thereby helping to slow or stop the proliferation of leukemia cells.

In simple terms, it is a targeted treatment that interferes with signals responsible for abnormal leukemia-cell growth.

9. Safety Advice

Because Bosutris is an anticancer prescription medicine, it should be used under appropriate specialist supervision.

Important safety considerations:

  • Inform the doctor about liver, kidney, heart or other medical conditions.
  • Regular blood counts and liver-function monitoring may be required.
  • Liver enzymes should be monitored particularly closely during the initial months of therapy.
  • Tell the doctor about all prescription medicines, OTC medicines, vitamins and supplements.
  • Bosutinib has important drug interactions, particularly with certain CYP3A inhibitors and inducers.
  • Proton-pump inhibitors may reduce bosutinib exposure; the prescribing information recommends considering short-acting antacids or H2 blockers as alternatives where appropriate.
  • Avoid grapefruit and grapefruit juice while taking bosutinib.
  • Bosutinib can cause fetal harm; patients who can become pregnant should discuss effective contraception with their healthcare professional.
  • Breastfeeding is not recommended during treatment and for the period specified in prescribing guidance.
  • Keep the medicine tightly closed and store it according to the product labeling.

Important: Bosutris should not be purchased, started, substituted or dose-adjusted without appropriate medical advice.

10. FAQs

Q1. What is Bosutris 100 mg Tablet?
Bosutris 100 mg is a prescription anticancer tablet containing bosutinib 100 mg.

Q2. What is Bosutris 100 mg used for?
It is used for certain forms of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).

Q3. Is Bosutris a chemotherapy medicine?
It is a targeted anticancer medicine and belongs to the tyrosine kinase inhibitor class rather than conventional cytotoxic chemotherapy.

Q4. How does Bosutris work?
It blocks abnormal kinase signaling involved in the growth and survival of leukemia cells.

Q5. Should Bosutris 100 mg be taken with food?
Bosutinib is generally administered with food. Follow the exact instructions provided by the treating physician.

Q6. Can Bosutris be stopped suddenly?
Do not stop bosutinib without consulting the prescribing doctor.

Q7. What are the common side effects?
Diarrhea, abdominal pain, nausea, vomiting, rash, fatigue, headache, fever and appetite loss are among reported adverse reactions.

Q8. Can Bosutris interact with other medicines?
Yes. Bosutinib has clinically important interactions with several medicines, including certain CYP3A inhibitors/inducers and acid-reducing medicines.

Q9. Can grapefruit be consumed with Bosutris?
Grapefruit and grapefruit juice should be avoided during bosutinib treatment.

Q10. Is Bosutris safe during pregnancy?
Bosutinib can cause fetal harm and should only be used after careful medical assessment. Discuss contraception and pregnancy planning with the treating physician.

Q11. Does Bosutris require a prescription?
Yes. It is a prescription anticancer medicine.

Q12. Does the 100 mg strength mean the patient should take 100 mg daily?
No. The tablet strength and the prescribed daily dose are not necessarily the same. The oncologist determines the appropriate regimen.

11. Substitute for Bosutris 100 mg

Possible alternatives containing the same active ingredient, bosutinib 100 mg, include brands such as Bonitar 100 Tablet and Bosuvi 100 mg Tablet, which are listed as same-composition alternatives in Indian pharmaceutical listings.

However, a substitute should never be selected solely on price or availability. The treating oncologist or pharmacist should confirm the appropriate brand, strength, formulation and regulatory status before switching.

12. SEO Keywords

For Phoenix Exim – Nagpur, India, suitable B2B SEO keywords include:

  1. Bosutris 100 mg Tablet exporter from India
  2. Bosutris 100 mg Tablet supplier India
  3. Bosutris 100 mg wholesale supplier
  4. Bosutris 100 mg pharmaceutical exporter
  5. Bosutris 100 mg tablets export from India
  6. Bosutinib 100 mg Tablet exporter India
  7. Bosutinib 100 mg pharmaceutical supplier
  8. Bosutinib 100 mg wholesale India
  9. Bosutinib 100 mg CML medicine supplier
  10. Bosutris 100 mg CML medicine exporter
  11. Bosutris 100 mg anti cancer medicine supplier
  12. Bosutinib tablets exporter from Nagpur
  13. Bosutris 100 mg exporter from Nagpur India
  14. Buy Bosutris 100 mg from India for wholesale
  15. Bosutinib 100 mg international pharmaceutical supplier
  16. Bosutris 100 mg medicine supplier USA
  17. Bosutris 100 mg medicine exporter UK
  18. Bosutris 100 mg pharmaceutical supplier Australia
  19. Bosutris 100 mg supplier Singapore
  20. Bosutris 100 mg exporter Canada
  21. Bosutris 100 mg supplier South Korea
  22. Bosutris 100 mg pharmaceutical exporter UAE
  23. Bosutinib 100 mg supplier USA UK Australia
  24. Bosutinib 100 mg exporter Canada Singapore UAE
  25. Ph+ CML medicine supplier India
  26. Chronic myeloid leukemia medicine exporter India
  27. Bosutinib CML treatment medicine supplier
  28. Targeted cancer medicine exporter from India
  29. Oncology medicine exporter Nagpur India
  30. Prescription cancer medicine supplier India
  31. Generic Bosutinib 100 mg exporter
  32. Bosutris 100 mg wholesale pharmaceutical supplier India
  33. Bosutinib 100 mg B2B medicine supplier
  34. Bosutris 100 mg international medicine exporter
  35. Phoenix Exim Bosutris 100 mg supplier
  36. Phoenix Exim Bosutinib 100 mg exporter
  37. Nagpur pharmaceutical exporter Bosutinib
  38. Indian oncology medicine exporter to USA UK
  39. Indian pharmaceutical supplier to Australia Canada UAE
  40. Bosutinib 100 mg export supplier for international buyers
Aug 13th, 2026 1:59 PM

Keywords